Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-51.53	70.04	144.50
Graham Fair Price	-60.85	1.61	4.10
PEG	-2844.72	-0.17	< 0.005
Price/Book	-26.75	0.27	0.37
Price/Cash Flow	23.54	10.52	8.51
Prices/Earnings	545.17	19.28	-2.99
Price/Sales	-25.46	0.66	0.89
Price/FCF	23.54	10.52	8.51
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.08	0.12	0.11
Operating Margin	-98.68	< 0.005	-0.08
ROA	-88.75	< 0.005	< 0.005
ROE	-0.03	< 0.005	-88.65
ROIC	< 0.005	< 0.005	-88.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	< 0.005	76.21
Dividends QOQ	0.04	-0.16	275.85
EBIT QOQ	-1.70	1.01	-40.47
EPS QOQ	-5.17	1.13	-78.09
FCF QOQ	-0.57	-0.41	28.54
Revenue QOQ	-0.04	-0.02	51.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	73.09	76.46	4.61
Days Sales Outstanding (DSO)	81.10	83.21	2.60
Inventory Turnover	1.23	1.18	-4.41
Debt/Capitalization	0.71	0.72	0.42
Quick Ratio	0.37	0.38	3.87
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.93	5.73	16.20
Cash	3.60	4.56	26.85
Capex	< 0.005	-0.02	-90.87
Free Cash Flow	0.21	0.15	-31.11
Revenue	2.04	2.32	14.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.57	0.58	1.40
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	119.77	60.70	-49.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating